Literature DB >> 8250620

Large vessel disease in CREST.

J J Belch, D J Veale, T Colleridge.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8250620      PMCID： PMC1005203          DOI： 10.1136/ard.52.11.837-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Raynaud's phenomenon: its relevance to scleroderma.

Authors:  J J Belch
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Vascular damage and factor-VIII-related antigen in the rheumatic diseases.

Authors:  J J Belch; A A Zoma; I M Richards; K McLaughlin; C D Forbes; R D Sturrock
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

3.  Large vessel occlusive disease associated with CREST syndrome and scleroderma.

Authors:  P Youssef; H Englert; J Bertouch
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

4.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.

Authors:  F G Fowkes; E Housley; E H Cawood; C C Macintyre; C V Ruckley; R J Prescott
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

5.  Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis.

Authors:  A Kahan; J Y Devaux; B Amor; C J Menkès; S Weber; A Nitenberg; A Venot; F Guérin; M Degeorges; J C Roucayrol
Journal:  N Engl J Med       Date:  1986-05-29       Impact factor: 91.245

6.  Decreased oesophageal blood flow in patients with Raynaud's phenomenon.

Authors:  J J Belch; D Land; R H Park; J H McKillop; J F MacKenzie
Journal:  Br J Rheumatol       Date:  1988-12
  6 in total
  1 in total

1.  Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.

Authors:  D J Veale; T A Collidge; J J Belch
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.